Beyond CLEOPATRA: When the 1L Standard Falls Short

While historic, the CLEOPATRA paradigm was not fully designed for the modern high-risk landscape—specifically patients with CNS involvement, aggressive biology, or prior HER2 exposure. This clip explores why in these cases, moving to T-DXd isn’t just an option; it’s a clinical necessity to overcome resistance and maximize frontline control.